Back to results
US 2008/0076767 A1Published application
Indazole, benzisoxazole, and benzisothiazole kinase inhibitors
AssigneeAbbott Laboratories
InventorsYujia Dai, Steven Davidsen, Anna Ericsson, Kresna Hartandi, Zhiqin Ji, Michael Michaelides
Life of this patent
Estimating the term…
Abstract
Compounds having the formula are useful for inhibiting protein tyrosine kinases. The present invention also discloses methods of making the compounds, compositions containing the compounds, and methods of treatment using the compounds.
Claims52
A compound of formula (I)
- or a therapeutically acceptable salt thereof, wherein
- A is selected from the group consisting of indolyl, phenyl, pyrazinyl, pyridazinyl, pyridinyl, pyrimidinyl, and thienyl;
- X is selected from the group consisting of O, S, and NR9;
- R1 and R2 are independently selected from the group consisting of hydrogen, alkoxy, alkoxyalkoxy, alkoxyalkyl, alkyl, aryl, arylalkyl, aryloxy, aryloxyalkyl, halo, haloalkoxy, haloalkyl, heterocyclyl, heterocyclylalkenyl, heterocyclylalkoxy, heterocyclylalkyl, heterocyclyloxyalkyl, hydroxy, hydroxyalkoxy, hydroxyalkyl, (NRaRb)alkoxy, (NRaRb)alkenyl, (NRaRb)alkyl, (NRaRb)alkynyl, (NRaRb)carbonylalkenyl, and (NRaRb)carbonylalkyl;
- R3, R4, and R5 are each independently selected from the group consisting of hydrogen, alkoxy, alkoxyalkoxy, alkyl, halo, haloalkoxy, haloalkyl, hydroxy, and LR6;
- provided that at least two of R3, R4, and R5 are other than LR6;
- L is selected from the group consisting of (CH2)mN(R7)C(O)N(R8)(CH2)n and CH2C(O)NR7, wherein m and n are independently 0 or 1, and wherein each group is drawn with its left end attached to A;
- R6 is selected from the group consisting of hydrogen, aryl, cycloalkyl, heterocyclyl, and 1,3-benzodioxolyl wherein the 1,3-benzodioxolyl can be optionally substituted with one, two, or three substituents independently selected from the group consisting of alkenyl, alkoxy, alkoxyalkyl, alkoxycarbonyl, alkyl, alkylcarbonyl, aryl, arylalkoxy, arylalkyl, aryloxy, carboxy, cyano, cycloalkyl, halo, haloalkoxy, haloalkyl, a second heterocyclyl group, heterocyclylalkyl, hydroxy, hydroxyalkyl, nitro, —NRcRd, and (NRcRd)alkyl;
- R7 and R8 are independently selected from the group consisting of hydrogen and alkyl;
- R9 is selected from the group consisting of hydrogen, alkenyl, alkoxyalkyl, alkyl, alkylcarbonyl, aryl, heterocyclylalkyl, hydroxyalkyl, and (NRaRb)alkyl;
- Ra and Rb are independently selected from the group consisting of hydrogen, alkenyl, alkyl, alkylcarbonyl, alkylsulfonyl, aryl, arylalkyl, arylcarbonyl, arylsulfonyl, haloalkylsulfonyl, cycloalkyl, heterocyclyl, heterocyclylalkyl, and heterocyclylsulfonyl;
- and
- Rc and Rd are independently selected from the group consisting of hydrogen, alkyl, alkylcarbonyl, aryl, arylalkyl, cycloalkyl, and heterocyclyl.
10 more elements
The compound of claim 34 selected from the group consisting of
- N-[4-(3-amino-1H-indazol-4-yl)-2,6-dimethylphenyl]-N′-(2-fluoro-5-methylphenyl)urea;
- and
- N-[4-(3-amino-1H-indazol-4-yl)-2,6-dimethylphenyl]-N′-[3-(trifluoromethyl)phenyl]urea.
The compound which is
- N-[4-(3-amino-1H-indazol-4-yl)phenyl]-N′-(2-fluoro-5-methylphenyl)urea.
The compound which is
- N-[4-(3-amino-1H-indazol-4-yl)phenyl]-N′-(3-chlorophenyl)urea;
The compound which is
- N-[4-(3-amino-1H-indazol-4-yl)-2-fluorophenyl]-N′-(2-fluoro-5-methylphenyl)urea.
The compound which is
- N-[4-(3-amino-1H-indazol-4-yl)-2-fluorophenyl]-N′-(3-chlorophenyl)urea.
The compound which is
- N-[4-(3-amino-1-methyl-1H-indazol-4-yl)phenyl]-N′-(3-methylphenyl)urea.
The compound selected from the group consisting of
- N-[4-(3-amino-1-methyl-1H-indazol-4-yl)phenyl]-N′-(2-fluoro-5-methylphenyl)urea.
- N-[4-(3-amino-1H-indazol-4-yl)phenyl]-N′-(4-fluoro-3-methylphenyl)urea
- N-[4-(3-amino-1H-indazol-4-yl)-2-fluorophenyl]-N′-[3-(trifluoromethyl)phenyl]urea;
- and
- N-[4-(3-amino-1H-indazol-4-yl)-3-fluorophenyl]-N′-(2-fluoro-5-methylphenyl)urea.
2 more elements
The compound selected from the group consisting of
- 4-(1H-indol-5-yl)-1H-indazol-3-amine;
- 4-(1H-indol-5-yl)-7-[3-(1H-pyrrol-1-yl)propoxy]-1H-indazol-3-amine;
- and
- N-(2-{[3-amino-4-(1H-indol-5-yl)-1H-indazol-7-yl]oxy}ethyl)thiophene-2-sulfonamide.
1 more element
Dependencies are inferred from the claim text.